pH Probe for Cancer Diagnostics One Step Closer to Clinical Trials

A probe, developed within IPAS and the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP), that allows the real-time detection of differences in pH (indicative of healthy vs. cancer tissue) was featured in Flinders University news.

Funding from the State Government’s Medical Technologies Program has allowed a team involving Dr Erik Schartner, Prof Mark Hutchinson, Prof Grantley Gill and Dr Elizaveta Klantsataya to work with biomedical engineers within Flinders University’s Medical Device Partnering Program (MDPP) to bring the technology one step closer to clinical trials.

More information can be found on the Flinders University news page.OLYMPUS DIGITAL CAMERA

Advertisements

Posted on June 28, 2017, in ipas, IPASnews and tagged , , , . Bookmark the permalink. Leave a comment.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: